Redeye notes that Smart Eye’s competitor Tobii yesterday received its first design win, though small...
Tuff start på 2023 men aktiviteten är hög och rörliga volymer återhämtas.
Redeye updates its estimates following Beijer Group’s Q1 2023 report, which was stronger than antici...
Q1: 31% organic sales growth and EBITA margin doubling We raise estimates on further signs of profit...
Redeye sees no big drama in the Q1 report and expect continued solid progress as the business pipeli...
Redeye returns with a more detailed take on Sedana Medical’s Q1 report, and we see signs of improved...
Redeye updates its estimates and valuation following Mentice’s Q1 2023 report.
Bra tillväxt i en utmanande miljö Bokusgruppen rapporterade ett starkt resultat givet de utmaningar ...
Inga överraskningar Egetis presenterade under onsdagen en Q1-rapport som var i linje med våra förvän...
Förlängd finansiering Vi överraskades av bolagets fina kostnadskontroll i Q1’23 och att rörelsekostn...
Flera pilotprojekt ARR uppgick till 18,3 mkr, vilket är ca 1% högre än vid årsskiftet och orderingån...
Starkaste första kvartalet i historien Orderingången i första kvartalet uppgick till 57,7 mkr, vilke...
Consti reported Q1 figures that were above our estimates.
SRV’s revenue declined clearly in Q1, as residential construction volumes were low, and profitabilit...
Finnair’s Q1 further demonstrated solid recovery, however valuation still demands a lot more long-te...
Loihde’s Q1 result came in below expectations. While net sales increased by 13%, adj.
Raute’s Q1 results came in clearly better than our estimates.
12% organic growth, EBITA margin of 15.1% (14.1%) Increased financial targets Positive estimate revi...
DT recorded strong Q1 growth while its profitability fell short of expectations.
Net profit in Q1 18% above ABGSCe driven by... ...loan loss reversals and investment portfolio earni...
